Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study)-Reference-Cited by-同舟云学术

Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study)

Published:2021-02 Issue: Volume:172 Page:108589
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Elhadd Tarik,Bashir Mohamed,Baager Khaled A.,Ali Hamda A.,Almohannadi Dabia H.S.,Dabbous Zainab,Malik Rayaz A.,Abou-Samra Abdul-Badie

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. International Diabetes Federation. IDF diabetes atlas 9th Edition [Internet]. IDF Diabetes Atlas - 9th Edition. 2019. Available from: http://www.diabetesatlas.org/.

2. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care [Internet]. 2004 Oct 1 [cited 2017 Dec 23];27(10):2306–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15451892.

3. Aravind SR, Ismail SB, Balamurugan R, Gupta JB, Wadhwa T, Loh SM, et al. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin [Internet]. 2012 Aug 6 [cited 2017 Dec 23];28(8):1289–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22738801.

4. Hui E, Bravis V, Salih S, Hassanein M, Devendra D. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Int J Clin Pract [Internet]. 2010 Mar 10 [cited 2017 Dec 23];64(8):1095–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20337752.

5. Cesur M, Corapcioglu D, Gursoy A, Gonen S, Ozduman M, Emral R, et al. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract [Internet]. 2007 Feb [cited 2017 Dec 23];75(2):141–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0168822706002294.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management;Diabetes Research and Clinical Practice;2023-07

2. Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial;Frontiers in Endocrinology;2023-01-26

3. Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial;Diabetes Care;2022-12-12

4. Diabetes Complications and Related Comorbidities Impair the Accuracy of FreeStyle Libre, a Flash Continuous Glucose Monitoring System, in Patients with Type 2 Diabetes;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-11

5. Safety and effectiveness of newer antidiabetic medications during Ramadan fasting and safety of Ramadan fasting after bariatric surgery;Journal of Diabetes & Metabolic Disorders;2022-10-24